This Week in Cancer Cell

Premium

Genetic inactivation of both β2-microglobulin and CD58 allows diffuse large B cell lymphoma to evade the immune system, report Columbia University researchers in Cancer Cell. The researchers found that, in 29 percent of cases, the β2-microglobulin gene is inactivated by mutations and deletions — preventing recognition by CD8+ cytotoxic T cells — and, in 21 percent of cases, the CD58 gene is mutated or deleted — affecting immune responses mediated by T and natural killer cells.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.